Immix Biopharma Announces Closing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants Biotech Investing
Medicenna Therapeutics to Host a Live Webinar with Q&A to Discuss Updated MDNA11 Clinical Data Life Science Investing
Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug Candidates Life Science Investing
Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors Life Science Investing
"LEQEMBI®" for the Treatment of Early Alzheimer's Disease Included in China's Commercial Insurance Innovative Drug List Life Science Investing
Incyte Presents Updated Positive Data at ASH 2025 Reinforcing the Potential of INCA033989, its First-in-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Essential Thrombocythemia Life Science Investing
Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting Life Science Investing
AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
